Medically reviewed by Jeff Steckler, OTD, OTR/L – Doctor of Occupational Therapy with 38+ years of clinical experience and former U.S. Army medic. Last reviewed March 26, 2026.
If you are searching for effective inflammation treatment near Modesto, you are in the right place. Advanced Recovery Cryotherapy provides evidence-based, non-pharmaceutical inflammation recovery using whole body cryotherapy, localized cryotherapy, compression therapy, Class IV laser, and multiple complementary modalities. Harvard Medical School reports that chronic inflammation contributes to 7 of the 10 leading causes of death in the United States – making inflammation management one of the most critical health priorities you can address today. At ARC in Modesto, Dr. Jeff Steckler designs personalized multi-modality protocols to reduce inflammation at its source and restore your quality of life.
This comprehensive inflammation treatment guide covers everything you need to make informed decisions about your recovery:
Inflammation is not just a medical buzzword – it is a biological process that, when left unchecked, becomes the root cause of nearly every chronic disease and pain condition you can name. And if you live and work in the Central Valley, your risk factors for chronic inflammation are significantly elevated.
The Journal of Internal Medicine (2022) estimates that chronic low-grade inflammation affects approximately 60% of American adults. In Stanislaus County and the greater Modesto area, several regional factors push that number even higher. Agricultural workers, warehouse employees, and construction laborers face daily physical demands that create repetitive micro-trauma and sustained inflammatory responses in joints, muscles, and connective tissue. The Central Valley’s extreme summer heat – regularly exceeding 100 degrees Fahrenheit from June through September – compounds this by increasing systemic stress hormones like cortisol, which directly amplify inflammatory pathways.
Agricultural chemical exposure adds another layer. The Central Valley is one of the most productive agricultural regions in the world, and residents face elevated exposure to pesticides, herbicides, and particulate matter that research has linked to increased systemic inflammation. A 2021 study in Environmental Health Perspectives found that agricultural pesticide exposure significantly elevated inflammatory biomarkers including C-reactive protein and IL-6 in nearby communities.
Then there is the aging population factor. Stanislaus County’s median age continues to rise, and age is one of the strongest independent predictors of chronic inflammation. The phenomenon known as “inflammaging” – the gradual increase in baseline inflammatory markers that occurs naturally with age – means that residents over 40 face compounding inflammation risks from both environmental and biological sources.
The consequences of untreated inflammation extend far beyond discomfort. Chronic inflammation drives the progression of arthritis, cardiovascular disease, type 2 diabetes, neurodegenerative conditions, and certain cancers. It accelerates joint degradation, delays wound healing, disrupts sleep, and creates persistent pain that erodes quality of life. For Central Valley workers whose livelihoods depend on physical capability, unmanaged inflammation is not just a health issue – it is an economic one.
This is exactly why Advanced Recovery Cryotherapy exists. Founded by Dr. Jeff Steckler – a Doctor of Occupational Therapy with 38+ years of clinical experience and a background as a U.S. Army medic – ARC provides Modesto and the surrounding Central Valley communities with access to advanced, evidence-based inflammation treatment that was previously available only in elite sports medicine facilities and major metropolitan medical centers.
ARC’s multi-modality approach targets inflammation through multiple biological mechanisms simultaneously: reducing circulating pro-inflammatory cytokines, improving lymphatic drainage, accelerating cellular repair, and restoring healthy blood flow to damaged tissues. Whether you are dealing with acute inflammation from a recent injury, chronic inflammation from years of physical labor, or autoimmune-driven inflammation from conditions like rheumatoid arthritis, ARC has the clinical expertise and advanced technology to help you recover.
To effectively treat inflammation, you first need to understand what it is, how it works, and why the distinction between acute and chronic inflammation determines your entire treatment approach.
Acute inflammation is your immune system’s immediate, protective response to tissue damage. When you sprain an ankle, strain a muscle, or have surgery, your body deploys an inflammatory cascade designed to isolate the injury, fight infection, and begin repair. You recognize acute inflammation by its five cardinal signs: redness (rubor), heat (calor), swelling (tumor), pain (dolor), and loss of function (functio laesa).
At the cellular level, this process begins within seconds. Damaged cells release chemical signals called damage-associated molecular patterns (DAMPs) that activate nearby immune cells. Mast cells in the tissue release histamine, which causes blood vessels to dilate (vasodilation) and become more permeable. This allows immune cells – primarily neutrophils and macrophages – to flood the injury site. These cells release pro-inflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1 beta) to coordinate the inflammatory response.
In a healthy system, acute inflammation resolves within days to weeks as the tissue heals. Anti-inflammatory mediators like interleukin-10 (IL-10) and specialized pro-resolving mediators (SPMs) gradually shut down the inflammatory cascade, and normal tissue function returns. This is inflammation working exactly as designed.
Chronic inflammation occurs when the inflammatory cascade fails to resolve. Instead of shutting down after tissue repair, the immune system continues producing pro-inflammatory cytokines at elevated levels – sometimes for months, years, or even decades. This sustained, low-grade inflammatory state causes progressive tissue damage rather than repair.
The World Health Organization reports that inflammation-related diseases are responsible for 3 out of every 5 deaths worldwide – making chronic inflammation arguably the single most important health factor in the modern world. Diseases driven or worsened by chronic inflammation include:
The key inflammatory biomarkers that clinicians use to measure chronic inflammation include C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and specific cytokine panels measuring IL-6, TNF-alpha, and IL-1 beta levels. When these markers remain persistently elevated, they indicate an inflammatory process that will not resolve on its own.
“What most people do not realize is that inflammation operates on a spectrum. You can have localized inflammation in a single joint that responds to targeted treatment, or you can have systemic inflammation where your entire body is in a low-grade inflammatory state. The treatment approach is fundamentally different for each – and at ARC, we have the modalities to address both. After 38 years in clinical practice, I can tell you that the patients who get the best outcomes are the ones who address inflammation early and aggressively with evidence-based protocols.” – Jeff Steckler, OTD, OTR/L
The conventional approach to inflammation management relies heavily on non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and naproxen, corticosteroid injections, and in severe cases, immunosuppressive medications. While these tools have their place, they come with significant limitations. NSAIDs carry risks of gastrointestinal bleeding, kidney damage, and cardiovascular events with long-term use. Corticosteroid injections can weaken tendons and cartilage over time. Immunosuppressive medications increase infection risk.
Advanced modalities like whole body cryotherapy, localized cryotherapy, Class IV laser therapy, and compression therapy offer a fundamentally different approach. They target the biological mechanisms of inflammation – vasoconstriction, cytokine modulation, lymphatic drainage, cellular repair – without the side effect profiles of pharmaceutical interventions. This is why elite athletes, sports medicine clinics, and now forward-thinking healthcare providers like ARC use these modalities as primary inflammation treatment tools.
Among all available non-pharmaceutical inflammation treatments, cryotherapy has emerged as the most extensively researched and clinically validated modality. The principle is straightforward: controlled exposure to extreme cold triggers a cascade of physiological responses that directly counteract the inflammatory process at every level – from circulating cytokines to local tissue swelling.
A landmark study published in Frontiers in Physiology (2023) demonstrated that a single whole body cryotherapy session reduces key inflammatory markers by 30-50%. This is not a gradual, subtle effect – it is a measurable, clinically significant reduction that occurs within hours of treatment. When combined with repeated sessions over a structured protocol, the anti-inflammatory effects become cumulative and increasingly long-lasting.
At Advanced Recovery Cryotherapy in Modesto, we use cryotherapy as the cornerstone of our inflammation protocols but rarely as a standalone treatment. Dr. Steckler’s approach combines multiple modalities – WBC, localized cryotherapy, compression therapy, Class IV laser, and other complementary treatments – to attack inflammation through multiple biological pathways simultaneously. This multi-modality approach consistently produces outcomes that exceed what any single treatment can achieve on its own.
The following sections detail each of ARC’s primary inflammation treatments, including the specific mechanisms of action, the peer-reviewed evidence supporting their use, and how Dr. Steckler integrates them into comprehensive recovery protocols.
Whole body cryotherapy (WBC) is ARC’s most powerful tool for systemic inflammation reduction. During a WBC session, you step into a cryotherapy chamber where your body is exposed to temperatures between -180 and -240 degrees Fahrenheit for 2-3 minutes. While these temperatures sound extreme, the treatment is well-tolerated by the vast majority of patients and does not involve direct contact with ice or liquid.
The anti-inflammatory mechanism of WBC operates through several interconnected pathways:
Systemic vasoconstriction: Extreme cold triggers an immediate, whole-body vasoconstriction response. Blood vessels throughout the body narrow, reducing blood flow to peripheral tissues and redirecting it to the body’s core. This rapid vasoconstriction physically reduces the delivery of pro-inflammatory mediators to inflamed tissues, providing immediate relief from swelling and inflammatory pressure.
Cytokine modulation: WBC directly reduces the production and circulation of pro-inflammatory cytokines including IL-6, TNF-alpha, and IL-1 beta. Simultaneously, it increases anti-inflammatory cytokines like IL-10. This shift in the cytokine balance is one of the most clinically significant effects of WBC and is the primary reason it outperforms traditional cold therapy for inflammatory conditions.
Metabolic rate reduction: Cold exposure reduces the metabolic rate of inflamed tissues, which decreases their oxygen demand and slows the production of inflammatory byproducts. This creates a more favorable environment for tissue repair and resolution of the inflammatory cascade.
Norepinephrine release: WBC triggers a significant release of norepinephrine – a neurotransmitter with potent anti-inflammatory properties. Norepinephrine inhibits the production of pro-inflammatory cytokines and modulates the immune response. Studies have shown that a single WBC session can increase norepinephrine levels by 200-300%, with effects lasting several hours post-treatment.
Endorphin cascade: The extreme cold stimulus triggers the release of endorphins and enkephalins, the body’s natural pain-relieving compounds. This provides immediate pain relief that complements the anti-inflammatory effects, allowing patients with painful inflammatory conditions to experience both reduced swelling and reduced pain simultaneously.
The peer-reviewed evidence supporting WBC for inflammation reduction is robust and growing:
At ARC, Dr. Steckler recommends whole body cryotherapy as the primary treatment for:
For conditions involving localized inflammation in a specific joint or tissue, WBC is typically combined with localized cryotherapy for targeted relief.
While whole body cryotherapy addresses inflammation system-wide, localized cryotherapy delivers concentrated cold therapy directly to specific inflamed areas. Using a controlled stream of vaporized nitrogen at approximately -40 degrees Fahrenheit, localized cryotherapy targets precise anatomical locations – a swollen knee, an inflamed shoulder, a post-surgical incision site – with pinpoint accuracy.
Targeted vasoconstriction: Unlike WBC which creates a systemic vasoconstrictive response, localized cryotherapy produces intense, site-specific vasoconstriction directly at the treatment area. Blood vessels in the inflamed tissue narrow dramatically, immediately reducing the delivery of inflammatory cells and mediators to the site. This provides rapid, visible swelling reduction that patients can often see and feel within minutes of treatment.
Nerve conduction velocity reduction: Localized extreme cold reduces the speed at which pain signals travel along peripheral nerves in the treatment area. This effect, known as reduced nerve conduction velocity, provides immediate pain relief at the inflammation site. Research has demonstrated that localized cryotherapy can reduce nerve conduction velocity by 33% or more, significantly diminishing the pain-inflammation feedback loop that perpetuates chronic inflammatory conditions.
Lymphatic stimulation: The rapid cooling and subsequent rewarming of tissue creates a pumping effect in the local lymphatic system, accelerating the removal of inflammatory waste products, excess fluid, and cellular debris from the treatment area. This lymphatic mobilization is particularly important for post-surgical and post-injury inflammation where edema is a primary concern.
Cellular metabolic suppression: By reducing the metabolic rate of cells in the treatment area, localized cryotherapy decreases the production of inflammatory byproducts at their source. This is especially effective for acute inflammation where the inflammatory cascade is actively producing cytokines and prostaglandins at elevated rates.
Dr. Steckler recommends localized cryotherapy as the primary or complementary treatment for:
Localized cryotherapy sessions typically last 5-10 minutes per treatment area and can be combined with WBC in the same visit for patients dealing with both systemic and localized inflammation simultaneously. This combination approach is one of the most requested protocols at ARC for patients with conditions like chronic pain involving multiple inflammatory sites.
Compression therapy using NormaTec sequential pneumatic compression is one of ARC’s most effective tools for inflammation-related edema and swelling. Originally developed by a physician bioengineer, NormaTec uses pulsating compression patterns that mimic the body’s natural muscle contractions and lymphatic pumping mechanisms to dramatically accelerate fluid clearance from inflamed tissues.
Lymphatic drainage acceleration: The lymphatic system is responsible for clearing inflammatory waste products, excess fluid, and dead cells from tissues. In inflamed areas, the lymphatic system is often overwhelmed by the volume of fluid and debris produced by the inflammatory response. NormaTec’s sequential compression pattern physically mobilizes lymphatic fluid, moving it from the extremities toward the trunk where it can be processed and eliminated. This directly reduces edema – the fluid component of inflammatory swelling.
Venous return enhancement: Inflammation often impairs normal venous return, allowing inflammatory mediators to pool in affected tissues and perpetuate the inflammatory cycle. Compression therapy counteracts this by mechanically assisting venous blood flow, clearing stagnant blood carrying inflammatory byproducts and replacing it with fresh, oxygenated blood that supports tissue repair.
Interstitial pressure normalization: Swollen, inflamed tissues develop elevated interstitial pressure that compresses blood vessels, nerves, and lymphatic channels – further impairing circulation and waste clearance. Sequential compression helps normalize this pressure, restoring healthy fluid dynamics in inflamed tissues.
Sari et al. (2019) published research demonstrating that intermittent pneumatic compression (IPC) produced superior outcomes compared to traditional cold packs for inflammation and edema reduction. The study found that IPC achieved greater and more sustained reductions in swelling, faster return of range of motion, and improved patient-reported outcomes. This finding is particularly significant because it demonstrates that the mechanical mobilization of inflammatory fluid through compression can be more effective than cold therapy alone for edema-dominant inflammatory conditions.
Compression therapy is most effective for:
At ARC, compression therapy sessions typically last 20-30 minutes and are frequently combined with cryotherapy in the same visit. Dr. Steckler often sequences WBC first to reduce circulating inflammatory cytokines, followed by compression therapy to flush the mobilized waste products through the lymphatic system. This one-two approach is particularly effective for patients with chronic inflammatory conditions.
Beyond cryotherapy and compression, Advanced Recovery Cryotherapy offers several additional modalities that target inflammation through distinct biological mechanisms. Dr. Steckler incorporates these treatments into personalized protocols based on the type, location, and severity of each patient’s inflammatory condition.
Class IV laser therapy uses high-powered photobiomodulation to reduce inflammation at the cellular level. The laser delivers specific wavelengths of light energy that penetrate deep into tissue, where they are absorbed by mitochondria – the energy-producing organelles in every cell. This triggers a cascade of cellular responses that directly counteract inflammation:
Bjordal et al. (2006) – Published in Photomedicine and Laser Surgery (PMID: 16495470), this systematic review and meta-analysis confirmed that photobiomodulation therapy produces significant, dose-dependent anti-inflammatory effects. The researchers found that Class IV laser therapy reduces inflammation through mechanisms distinct from cold therapy, making it an ideal complementary treatment to cryotherapy.
The infrared cocoon uses far-infrared wavelengths to deliver deep tissue heating that paradoxically promotes anti-inflammatory responses. While cold therapy reduces inflammation through vasoconstriction and metabolic suppression, infrared therapy works through a different pathway: it activates heat shock proteins (HSPs) that protect cells from inflammatory damage and stimulates the production of nitric oxide, which improves circulation and accelerates the delivery of anti-inflammatory mediators to damaged tissues.
Infrared therapy is particularly effective for chronic inflammatory conditions where improved circulation is needed to break the cycle of inflammation, poor blood flow, tissue damage, and more inflammation. It is also beneficial for patients who cannot tolerate extreme cold or who need deep tissue warming to address inflammation in muscles and fascia.
Cupping therapy uses suction to lift tissue layers, creating space between muscle, fascia, and skin that dramatically increases local blood flow. This mechanical separation of tissue layers breaks up adhesions and stagnant areas where inflammatory waste products accumulate, while simultaneously flooding the area with fresh, oxygenated blood containing anti-inflammatory mediators.
Li et al. (2017) – Published in Evidence-Based Complementary and Alternative Medicine (PMID: 29317898), this systematic review found that cupping therapy produces significant anti-inflammatory effects, with measurable reductions in inflammatory biomarkers and meaningful improvements in patient-reported pain and function scores. The mechanical stimulus of cupping also activates the body’s own anti-inflammatory pathways through controlled microtrauma.
Graston technique and instrument-assisted soft tissue mobilization (IASTM) use specialized stainless steel instruments to detect and break down fascial restrictions, scar tissue, and adhesions that trap inflammatory mediators in tissue. By mechanically disrupting these restrictions, IASTM restores normal tissue mobility and fluid dynamics, allowing the lymphatic system to clear accumulated inflammatory waste. This modality is particularly effective for chronic tendinitis, fasciitis, and post-surgical scar tissue where inflammation has been sustained by physical tissue restrictions.
Dr. Steckler’s background as an occupational therapist gives him advanced expertise in soft tissue assessment and treatment that most cryotherapy facilities cannot match. His ability to identify tissue restrictions through palpation and address them with IASTM before applying cryotherapy creates a comprehensive treatment sequence that targets inflammation at both the structural and biochemical levels.
One of the most important things that sets Advanced Recovery Cryotherapy apart from other treatment facilities is Dr. Steckler’s protocol-driven approach to inflammation. Rather than applying a one-size-fits-all treatment, he designs specific multi-modality protocols based on the type of inflammation, its cause, its duration, and the patient’s overall health profile.
Condition: Recent sprains, strains, muscle tears, contusions – inflammation less than 72 hours old
Protocol: Localized cryotherapy (10 min on injury site) followed by compression therapy (20 min). Repeat daily for 3-5 days, then reassess. WBC may be added after the acute phase to accelerate systemic recovery.
Expected timeline: Significant swelling reduction within 2-3 sessions. Full inflammatory resolution 40-60% faster than RICE protocol alone.
Condition: Persistent joint inflammation from osteoarthritis, repetitive stress, or overuse – inflammation lasting weeks to months
Protocol: WBC (3 min) followed by localized cryotherapy on affected joints (8 min each) followed by compression therapy (20 min). 3 sessions per week for 4-6 weeks, then transition to 1-2 weekly maintenance sessions. Class IV laser added for joints with deep tissue involvement.
Expected timeline: Measurable reduction in inflammatory markers within 2 weeks. Significant functional improvement by 4-6 weeks.
Condition: Controlled inflammation following surgical procedures (knee replacement, ACL reconstruction, rotator cuff repair, spinal surgery)
Protocol: Begin 48-72 hours post-surgery (physician clearance required). Localized cryotherapy on surgical site (8 min) followed by compression therapy (20 min). Daily for the first week, then every other day for weeks 2-4. Class IV laser added at week 2 to accelerate tissue repair. WBC introduced when incision is fully closed.
Expected timeline: Faster edema resolution and earlier return to rehabilitation milestones compared to ice-only protocols.
Condition: Active flares from RA, psoriatic arthritis, lupus, ankylosing spondylitis, or other autoimmune conditions
Protocol: WBC (3 min) as the primary systemic anti-inflammatory treatment. Localized cryotherapy on the most severely affected joints (8 min each). Infrared cocoon on non-flare days for gentle circulation support. 4-5 sessions per week during active flares, reducing to 2-3 weekly as flare subsides.
Expected timeline: Significant symptom relief within 3-5 WBC sessions. Ongoing maintenance prevents flare severity and frequency.
| Treatment | Best For | Mechanism | Duration | Evidence Level |
|---|---|---|---|---|
| Whole Body Cryotherapy | Systemic inflammation, autoimmune flares, multi-site inflammation | Systemic vasoconstriction, cytokine modulation, norepinephrine release | 2-3 minutes | Strong (multiple RCTs) |
| Localized Cryotherapy | Single-joint inflammation, tendinitis, post-surgical swelling | Targeted vasoconstriction, nerve conduction reduction, lymphatic pumping | 5-10 minutes per area | Strong (systematic reviews) |
| Compression Therapy | Edema, post-surgical swelling, lymphatic congestion | Sequential pneumatic compression, lymphatic drainage, venous return | 20-30 minutes | Strong (RCT – superior to cold packs) |
| Class IV Laser | Deep tissue inflammation, chronic tendinitis, fascial inflammation | Photobiomodulation, mitochondrial activation, PGE2/COX-2 reduction | 10-15 minutes per area | Strong (meta-analysis) |
| Infrared Cocoon | Chronic muscle inflammation, stiffness, circulation-related inflammation | Heat shock protein activation, nitric oxide production, deep tissue heating | 30-45 minutes | Moderate (clinical studies) |
| Cupping Therapy | Fascial inflammation, muscle tightness, adhesion-related inflammation | Tissue separation, blood flow increase, adhesion breakdown | 15-20 minutes | Moderate (systematic review) |
| Graston / IASTM | Scar tissue inflammation, fascial restrictions, chronic tendinopathy | Mechanical tissue disruption, fascial release, lymphatic mobilization | 10-15 minutes per area | Moderate (clinical studies) |
“I design every inflammation protocol around the individual, not the modality. Two patients can walk in with the same swollen knee and need completely different treatment plans based on the underlying cause – whether it is acute trauma, degenerative arthritis, autoimmune activity, or post-surgical recovery. That is why having 16+ modalities available under one roof matters. It lets me match the right tools to the right problem every time.” – Jeff Steckler, OTD, OTR/L
Most patients experience noticeable inflammation reduction within 24-48 hours of their first whole body cryotherapy session. Research published in Frontiers in Physiology (2023) demonstrated that a single WBC session can reduce key inflammatory markers like IL-6, TNF-alpha, and C-reactive protein by 30-50%. At Advanced Recovery Cryotherapy in Modesto, many patients report decreased swelling, reduced redness, and improved range of motion after just one treatment. For acute inflammatory conditions like recent sports injuries or post-surgical swelling, localized cryotherapy can produce visible swelling reduction within minutes during the treatment itself. For chronic inflammatory conditions, Dr. Jeff Steckler typically recommends an initial protocol of 3-5 sessions within the first two weeks to achieve cumulative anti-inflammatory effects. Each subsequent session builds on the previous one, producing progressively longer-lasting inflammation reduction. Most chronic inflammation patients report significant, sustained improvement within 2-4 weeks of beginning a structured protocol.
Yes – cryotherapy and traditional ice packs both use cold to reduce inflammation, but they work through fundamentally different and non-comparable mechanisms. Ice packs provide surface-level cooling that penetrates only 1-2 centimeters into tissue and must be applied for 15-20 minutes to achieve meaningful temperature reduction. The therapeutic effect is limited to the immediate area of application, and ice packs cannot trigger the systemic anti-inflammatory cascade that whole body cryotherapy produces. Whole body cryotherapy exposes the entire body to temperatures between -180 and -240 degrees Fahrenheit for just 2-3 minutes, activating the central nervous system’s cold response. This triggers whole-body vasoconstriction, reduces circulating pro-inflammatory cytokines systemically, stimulates a significant norepinephrine release (200-300% increase), and activates the endorphin system. Banfi et al. (2010) demonstrated that WBC significantly reduces IL-6 and C-reactive protein levels throughout the entire body – an effect that ice packs simply cannot replicate. Ice packs remain useful for immediate first aid (the first 15-30 minutes after an injury), but for structured inflammation treatment, cryotherapy delivers superior and longer-lasting outcomes.
Yes. Cryotherapy has shown significant promise for managing autoimmune-driven inflammation. Conditions like rheumatoid arthritis, psoriatic arthritis, lupus, ankylosing spondylitis, and other autoimmune diseases involve an overactive immune response that produces excessive inflammatory cytokines – particularly TNF-alpha and IL-6 – even without tissue injury. Whole body cryotherapy helps modulate this dysfunctional immune response by reducing circulating levels of these pro-inflammatory cytokines while simultaneously increasing anti-inflammatory IL-10 production. Pournot et al. (2011) confirmed this dual effect in a peer-reviewed study. At ARC, Dr. Steckler designs autoimmune inflammation protocols that combine WBC with localized cryotherapy on the most affected joints, compression therapy for associated edema, and Class IV laser therapy for deep tissue involvement. These treatments complement your current rheumatology care and immunosuppressive medications – they do not replace them. Many autoimmune patients report reduced flare severity, decreased flare frequency, and improved daily function when cryotherapy is added to their existing treatment regimen.
Treatment frequency depends on the type and severity of your inflammation. Dr. Steckler tailors every schedule to the individual, but general frameworks include: For acute inflammation (sports injuries, post-surgical swelling), daily or every-other-day sessions for the first 1-2 weeks until the acute inflammatory phase resolves. For chronic joint inflammation (arthritis, tendinitis, bursitis), 3 sessions per week for 4-6 weeks to break the chronic inflammatory cycle, then transition to 1-2 weekly maintenance sessions. For autoimmune flares, 4-5 sessions per week during active flares, reducing to 2-3 weekly as the flare subsides, with ongoing maintenance of 1-2 sessions weekly. For general inflammation management and prevention (elevated CRP, overall wellness), 1-2 sessions per week on an ongoing basis. During your first visit to Advanced Recovery Cryotherapy, Dr. Steckler will assess your inflammatory condition, review any available lab work (CRP, ESR, cytokine panels), evaluate your pain and functional levels, and create a personalized treatment schedule with clear milestones.
Whole body cryotherapy (WBC) treats inflammation system-wide by exposing your entire body to extreme cold (-180 to -240 degrees Fahrenheit) for 2-3 minutes. This triggers a systemic anti-inflammatory response mediated by the central nervous system: circulating pro-inflammatory cytokines decrease throughout the bloodstream, norepinephrine levels surge, and anti-inflammatory IL-10 increases. WBC is ideal for widespread inflammation, conditions affecting multiple joints, autoimmune flares, and chronic low-grade systemic inflammation (elevated CRP without a single identifiable source). Localized cryotherapy targets a specific anatomical area with concentrated cold (approximately -40 degrees Fahrenheit) for 5-10 minutes. It produces intense, site-specific vasoconstriction, reduces nerve conduction velocity at the treatment site for immediate pain relief, and stimulates local lymphatic drainage. Localized cryo is best for isolated inflammatory conditions: a single swollen knee, an inflamed Achilles tendon, a post-surgical incision site. At ARC, Dr. Steckler frequently combines both modalities in a single session – WBC first for systemic cytokine reduction, followed by localized cryo on the most affected area for targeted relief. This combination approach addresses inflammation at both the systemic and local levels simultaneously.
Absolutely – and in fact, combining modalities is one of the most effective strategies for inflammation reduction. Multi-modality sessions are one of ARC’s greatest advantages. A typical combination session might follow this sequence: Start with whole body cryotherapy (3 minutes) to trigger systemic anti-inflammatory cytokine changes. Follow with localized cryotherapy (8-10 minutes) on the most inflamed area for concentrated, targeted relief. Then apply compression therapy (20 minutes) to flush inflammatory waste products through the lymphatic system. Dr. Steckler may also incorporate Class IV laser therapy to reduce inflammatory mediators at the cellular level, cupping therapy to break up fascial adhesions trapping inflammatory fluid, or Graston/IASTM to address structural restrictions contributing to sustained inflammation. Research consistently demonstrates that multimodal approaches produce greater and longer-lasting inflammation reduction than any single treatment alone. ARC offers package pricing for combination sessions that makes multi-modality treatment more accessible than booking each service individually.
Advanced Recovery Cryotherapy offers first-time sessions starting at just $20, making it easy to experience the anti-inflammatory benefits of cryotherapy without a large financial commitment upfront. Regular session pricing varies by modality: whole body cryotherapy, localized cryotherapy, compression therapy, Class IV laser, cupping, infrared cocoon, and Graston/IASTM are each priced individually and available in multi-session packages and monthly memberships at reduced per-session rates. ARC is a self-pay wellness facility – most insurance plans do not currently cover cryotherapy or complementary modalities. However, many patients find that proactive inflammation treatment costs significantly less than the alternatives: ongoing NSAID prescriptions and their associated side effects, specialist copays, corticosteroid injections ($200-$500 each), and the productivity losses and quality-of-life costs associated with living with unmanaged chronic inflammation. For current pricing, packages, and membership options, contact ARC at (209) 605-6737 or visit advancedrecoverycryo.com/appointments.
No referral is needed to begin inflammation treatment at Advanced Recovery Cryotherapy. You can book your first appointment directly online at advancedrecoverycryo.com/appointments or by calling (209) 605-6737. During your initial visit, Dr. Jeff Steckler – a Doctor of Occupational Therapy with 38+ years of clinical experience and a background as a U.S. Army medic – will conduct a thorough assessment of your inflammatory condition. This includes reviewing your medical history, any available lab work (CRP, ESR, inflammatory markers), current medications and supplements, pain and function levels, and treatment goals. Based on this assessment, he will design a personalized multi-modality inflammation treatment plan with clear timelines and milestones. If you are currently under the care of a physician, rheumatologist, or orthopedic specialist for your inflammatory condition, ARC is happy to coordinate with your healthcare team to ensure integrated, collaborative care. Many physicians in the Modesto area refer patients to ARC for complementary inflammation treatment alongside their medical management.
Chronic inflammation does not resolve on its own – and every week you wait, inflammatory damage continues to accumulate in your joints, muscles, and tissues. At Advanced Recovery Cryotherapy, Dr. Jeff Steckler and his team provide the most comprehensive, evidence-based inflammation treatment available in the Central Valley.
Your first session starts at just $20.
Take the first step toward reducing your inflammation and reclaiming your quality of life:
Book Online: advancedrecoverycryo.com/appointments
Call Us: (209) 605-6737
Visit Us: 4660 Spyres Way, Modesto, CA 95356
Advanced Recovery Cryotherapy proudly serves patients from across the Central Valley, including Modesto, Turlock, Ceres, Riverbank, Oakdale, Manteca, Stockton, Tracy, Patterson, Newman, Hughson, Waterford, Ripon, Escalon, Salida, Empire, and surrounding communities in Stanislaus County and San Joaquin County.
Advanced Recovery Cryotherapy is Modesto’s premier recovery and wellness facility, founded and directed by Jeff Steckler, OTD, OTR/L – a Doctor of Occupational Therapy with 38+ years of clinical experience and a background as a U.S. Army medic.
Dr. Steckler’s unique combination of military medical training, decades of hands-on clinical practice, and advanced doctoral education gives him a depth of expertise in musculoskeletal conditions, inflammatory disorders, and recovery science that is unmatched in the Central Valley. His approach is rooted in evidence-based medicine: every treatment protocol at ARC is informed by peer-reviewed clinical research and refined through thousands of patient interactions.
ARC offers 16+ treatment modalities under one roof, including whole body cryotherapy, localized cryotherapy, Class IV laser therapy, NormaTec compression therapy, infrared cocoon, cupping therapy, Graston/IASTM, assisted stretching, BrainTap neurofeedback, and more. This breadth of treatment options allows Dr. Steckler to design truly personalized recovery protocols that address each patient’s unique combination of conditions, rather than forcing a one-size-fits-all approach.
Located at 4660 Spyres Way, Modesto, CA 95356, ARC serves patients from across the Central Valley. To learn more or schedule your first visit, call (209) 605-6737 or book online at advancedrecoverycryo.com/appointments.